These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15458385)

  • 21. Refined crystallographic structure of Pseudomonas aeruginosa exotoxin A and its implications for the molecular mechanism of toxicity.
    Wedekind JE; Trame CB; Dorywalska M; Koehl P; Raschke TM; McKee M; FitzGerald D; Collier RJ; McKay DB
    J Mol Biol; 2001 Dec; 314(4):823-37. PubMed ID: 11734000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity.
    Gallant CV; Raivio TL; Olson JC; Woods DE; Storey DG
    Microbiology (Reading); 2000 Aug; 146 ( Pt 8)():1891-1899. PubMed ID: 10931893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stealth and mimicry by deadly bacterial toxins.
    Yates SP; Jørgensen R; Andersen GR; Merrill AR
    Trends Biochem Sci; 2006 Feb; 31(2):123-33. PubMed ID: 16406634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping the enzymatic active site of Pseudomonas aeruginosa exotoxin A.
    Brandhuber BJ; Allured VS; Falbel TG; McKay DB
    Proteins; 1988; 3(3):146-54. PubMed ID: 3151219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunochemical analysis of Pseudomonas aeruginosa exotoxin A. Analysis of the His426 determinant.
    McGowan JL; Kessler SP; Anderson DC; Galloway DR
    J Biol Chem; 1991 Mar; 266(8):4911-6. PubMed ID: 1705936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of peptide inhibitors of Pseudomonas aeruginosa exotoxin A function using a yeast two-hybrid approach.
    Thompson C; Merrill AR; Mangroo D
    FEMS Microbiol Lett; 2003 Jan; 218(1):85-92. PubMed ID: 12583902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
    Han S; Arvai AS; Clancy SB; Tainer JA
    J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Father, Son and Cholix Toxin: The Third Member of the DT Group Mono-ADP-Ribosyltransferase Toxin Family.
    Lugo MR; Merrill AR
    Toxins (Basel); 2015 Jul; 7(8):2757-72. PubMed ID: 26213968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A re-evaluation of the role of histidine-426 within Pseudomonas aeruginosa exotoxin A.
    Roberts TM; Merrill AR
    Biochem J; 2002 Nov; 367(Pt 3):601-8. PubMed ID: 12160465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative immunochemistry of two fragments from domains Ib and III of Pseudomonas aeruginosa exotoxin A.
    Rutault K; Vacheron MJ; Guinand M; Michel G
    Infect Immun; 1993 Dec; 61(12):5417-20. PubMed ID: 8225617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pocket analysis of the full-length cholix toxin. An assessment of the structure-dynamics of the apo catalytic domain.
    Lugo MR; Merrill AR
    J Biomol Struct Dyn; 2015; 33(11):2452-68. PubMed ID: 25559625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and immunochemical studies of proteolytic fragments of exotoxin A from Pseudomonas aeruginosa.
    Bourdenet S; Vacheron MJ; Guinand M; Michel G; Arminjon F
    Eur J Biochem; 1990 Sep; 192(2):379-85. PubMed ID: 2170123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ARTT motif and a unified structural understanding of substrate recognition in ADP-ribosylating bacterial toxins and eukaryotic ADP-ribosyltransferases.
    Han S; Tainer JA
    Int J Med Microbiol; 2002 Feb; 291(6-7):523-9. PubMed ID: 11890553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conserved structural motif for recognizing nicotinamide adenine dinucleotide in poly(ADP-ribose) polymerases and ADP-ribosylating toxins: implications for structure-based drug design.
    Lee YM; Babu CS; Chen YC; Milcic M; Qu Y; Lim C
    J Med Chem; 2010 May; 53(10):4038-49. PubMed ID: 20420408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution.
    Allured VS; Collier RJ; Carroll SF; McKay DB
    Proc Natl Acad Sci U S A; 1986 Mar; 83(5):1320-4. PubMed ID: 3006045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newly discovered and characterized antivirulence compounds inhibit bacterial mono-ADP-ribosyltransferase toxins.
    Turgeon Z; Jørgensen R; Visschedyk D; Edwards PR; Legree S; McGregor C; Fieldhouse RJ; Mangroo D; Schapira M; Merrill AR
    Antimicrob Agents Chemother; 2011 Mar; 55(3):983-91. PubMed ID: 21135177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. His-426 of the Pseudomonas aeruginosa exotoxin A is required for ADP-ribosylation of elongation factor II.
    Wozniak DJ; Hsu LY; Galloway DR
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):8880-4. PubMed ID: 3143111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Inhibitors of Pseudomonas aeruginosa Exotoxin-S ADP-Ribosyltransferase Activity.
    Pinto AF; Ebrahimi M; Saleeb M; Forsberg Å; Elofsson M; Schüler H
    J Biomol Screen; 2016 Jul; 21(6):590-5. PubMed ID: 26850638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal structure and site-directed mutagenesis of enzymatic components from Clostridium perfringens iota-toxin.
    Tsuge H; Nagahama M; Nishimura H; Hisatsune J; Sakaguchi Y; Itogawa Y; Katunuma N; Sakurai J
    J Mol Biol; 2003 Jan; 325(3):471-83. PubMed ID: 12498797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional analysis of exotoxin A-related protein of Pseudomonas aeruginosa lacking residues 225-412.
    Guidi-Rontani C
    FEMS Microbiol Lett; 1991 May; 64(1):103-9. PubMed ID: 1906825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.